晨间信号Morning Signal
《女性健康》 第23卷 第3期 · 2026年夏季刊 · 中文解读

女性睾酮的狂野西部:从处方困境到自我用药

Welcome to the Wild West of Testosterone · Rachel Epstein
约 15 分钟Features在小程序里点播,20 到 60 分钟做好
这篇讲什么
本文探讨了女性使用睾酮的现状,包括FDA批准缺失、处方困难、剂量争议以及女性转向在线获取更高剂量睾酮的现象。
原文开头
With no FDA-approved product for women, sourcing and dosing of the hormone have become messy gray areas. How did we get here, and what does testosterone actually do for our bodies? Women’s Health investigates. On an early December morning in 2019, a panel of visitors to the Food and Drug Administration gathered at a hotel outside of Washington, D.C., to review some data. A pharmaceutical giant named AMAG Pharmaceuticals had petitioned the FDA to approve a testosterone product for women who were surgically induced into menopause and experiencing hypoactive sexual desire disorder (HSDD). After six months of clinical trials, the FDA was ready to make a market decision. Testosterone, however, has largely remained in the shadows until now. …
摘自《女性健康》(Women's Health)第23卷 第3期 · 2026年夏季刊,Rachel Epstein。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章